
Aerie Pharmaceuticals AERI
Aerie Pharmaceuticals Shares | AERI
Annual Shares Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.3 M | 45.9 M | 45.4 M | 41.7 M | 35.3 M | 29.1 M | 25.8 M | 24.1 M | 4.96 M | 955 K | 926 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.3 M | 926 K | 27.3 M |
Quarterly Shares Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 47.8 M | 47.6 M | 47.5 M | 48.4 M | 46.3 M | 46.2 M | 46.1 M | 46.8 M | 45.9 M | 45.9 M | 45.8 M | 46.5 M | 45.4 M | 45.4 M | 45.3 M | 45.5 M | 43.7 M | 39.2 M | 38.6 M | 36.9 M | 36.2 M | 34.8 M | 33.8 M | 33.5 M | 29.4 M | 26.8 M | 26.7 M | 26.5 M | 26.1 M | 25.8 M | 24.6 M | 24 M | 24.3 M | 23.9 M | 23.7 M | 23.3 M | 1.01 M | 982 K | 965 K | 965 K | 965 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48.4 M | 965 K | 32.9 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ProPhase Labs
PRPH
|
8.49 M | - | - | $ 5.07 M | ||
|
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
1.91 M | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
389 M | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
53.7 M | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
42.4 M | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
30.9 M | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | ||
|
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M | ||
|
OrganiGram Holdings
OGI
|
95.3 M | $ 0.93 | 1.64 % | $ 88.6 M | ||
|
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
1.68 M | $ 1.14 | -1.72 % | $ 1.92 M | ||
|
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | ||
|
Cronos Group
CRON
|
383 M | $ 2.81 | 2.55 % | $ 1.08 B | ||
|
TherapeuticsMD
TXMD
|
11.6 M | $ 2.06 | - | $ 23.8 M | ||
|
Jupiter Wellness
JUPW
|
4.01 M | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | ||
|
Canopy Growth Corporation
CGC
|
298 M | $ 0.89 | -1.82 % | $ 265 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
14.9 M | $ 6.61 | -5.37 % | $ 98.2 M | ||
|
Neoleukin Therapeutics
NLTX
|
21.3 M | - | - | $ 193 M | ||
|
Assertio Holdings
ASRT
|
6.4 M | - | - | $ 150 M | ||
|
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
29.1 B | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
10.2 M | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
42.7 M | - | - | $ 55.5 M | ||
|
Zomedica Corp.
ZOM
|
980 M | - | -0.21 % | $ 98 M | ||
|
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | ||
|
Perrigo Company plc
PRGO
|
138 M | $ 10.09 | -0.1 % | $ 1.4 B | ||
|
Bausch Health Companies
BHC
|
371 M | $ 4.43 | -0.45 % | $ 1.64 B | ||
|
Emergent BioSolutions
EBS
|
53.5 M | $ 7.26 | -3.2 % | $ 388 M | ||
|
China Pharma Holdings
CPHI
|
4.29 M | $ 1.52 | -18.28 % | $ 6.52 M | ||
|
Aurora Cannabis
ACB
|
54.8 M | $ 2.67 | -0.74 % | $ 146 M | ||
|
Harrow Health
HROW
|
36.8 M | $ 38.45 | -8.19 % | $ 1.41 B | ||
|
SCYNEXIS
SCYX
|
49.9 M | $ 3.73 | -5.81 % | $ 186 M | ||
|
Evolus
EOLS
|
64.5 M | $ 5.98 | -0.17 % | $ 386 M | ||
|
Rockwell Medical
RMTI
|
36 M | $ 6.63 | 1.61 % | $ 239 M | ||
|
Solid Biosciences
SLDB
|
87.5 M | $ 7.83 | -1.88 % | $ 685 M | ||
|
Relmada Therapeutics
RLMD
|
39.5 M | $ 5.18 | -0.38 % | $ 205 M | ||
|
Veru
VERU
|
14.6 M | $ 2.25 | -2.6 % | $ 33 M | ||
|
Organogenesis Holdings
ORGO
|
127 M | $ 2.39 | -1.65 % | $ 303 M | ||
|
Pacira BioSciences
PCRX
|
46.2 M | $ 25.88 | -0.19 % | $ 1.2 B | ||
|
Sundial Growers
SNDL
|
258 M | $ 1.25 | -0.4 % | $ 323 M | ||
|
cbdMD
YCBD
|
4.02 M | $ 0.54 | -6.6 % | $ 2.17 M | ||
|
Tilray
TLRY
|
618 M | $ 3.88 | -2.76 % | $ 2.4 B |